Role of Free Fatty Acids in Human Insulin Metabolism
游离脂肪酸在人体胰岛素代谢中的作用
基本信息
- 批准号:6755036
- 负责人:
- 金额:$ 31.31万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-06-01 至 2006-04-30
- 项目状态:已结题
- 来源:
- 关键词:clearance rateclinical researchdietary lipidfree fatty acidsglucose clamp techniqueglucose tolerancehormone metabolismhuman subjecthyperinsulinisminsulininsulin sensitivity /resistancelipid metabolismliver cellsmuscle cellsnoninsulin dependent diabetes mellitusnoninvasive diagnosisnuclear magnetic resonance spectroscopynutrition related tagpancreatic islet functionsaturated fatty acidsstable isotopetriglyceridesunsaturated fatty acids
项目摘要
Increased availability of lipid substrates, particularly plasma non-esterified free fatty acids and intracellular triglyceride stores have been linked to many aspects of the insulin resistance syndrome including obesity, dyslipidemia and Type 2 diabetes. Epidemiologic and animal data suggest that saturated fats have differential effects on the induction of insulin resistance as well as their effects (both stimulatory and inhibitory) on beta cell function compared to unsaturated fats. Current medical guidelines suggest limiting fat, particularly saturated fat intake. Surprisingly, considering the potential public health implications of dietary fat intake, little direct experimental data exists for human subjects in this area, and available data is contradictory. The goal of these studies, therefore, is to explore the effect of lipids on normal beta cell physiology and then to directly test the hypothesis that dietary saturated fatty acids time dependently stimulate insulin secretion more and then induce greater degrees of insulin secretory dysfunction with prolonged exposure as compared to unsaturated fats using the novel method of in vivo stable isotope peptide pharmacokinetics. As beta cell function deteriorates with prolonged NEFA exposure, hyperinsulinemia matching the degree of insulin resistance will be maintained by decreases in systemic and hepatic insulin clearance. We will also test the proposition that subjects at risk for Type 2 diabetes will be more sensitive to the effects of saturates compared to normal controls. Lastly we hypothesize that for the group as a whole, defects in insulin action, insulin clearance and finally beta cell secretory function will be exactly paralleled by accumulations of intracellular triglycerides in multiple tissues including within hepatocytes and skeletal myocytes as monitored non-invasively by magnetic resonance proton spectroscopy and that this provides the unifying link to systemic organ dysfunction with abnormal lipid metabolism in the insulin resistance syndromes. Preliminary data support the feasibility of our approach as well as our hypothesis. An improved understanding of beta cell - lipid interactions should provide evidence for future dietary recommendations to prevent type 2 diabetes.
脂质底物,特别是血浆非酯化游离脂肪酸和细胞内甘油三酯储存的可用性增加与胰岛素抵抗综合征的许多方面有关,包括肥胖症、血脂异常和2型糖尿病。 流行病学和动物数据表明,与不饱和脂肪相比,饱和脂肪对胰岛素抵抗的诱导以及对β细胞功能的影响(刺激和抑制)具有不同的作用。目前的医学指南建议限制脂肪,特别是饱和脂肪的摄入。 令人惊讶的是,考虑到膳食脂肪摄入的潜在公共卫生影响,在这方面几乎没有直接的实验数据存在于人类受试者,现有的数据是矛盾的。 因此,这些研究的目的是探索脂质对正常β细胞生理学的影响,然后使用体内稳定同位素肽药代动力学的新方法,直接测试以下假设:与不饱和脂肪相比,膳食饱和脂肪酸时间依赖性地刺激胰岛素分泌更多,然后诱导更大程度的胰岛素分泌功能障碍。 由于β细胞功能随着长期NEFA暴露而恶化,与胰岛素抵抗程度相匹配的高胰岛素血症将通过全身和肝脏胰岛素清除率的降低来维持。 我们还将测试这样的命题,即与正常对照相比,有2型糖尿病风险的受试者对饱和物的影响更敏感。 最后,我们假设,对于整个组,胰岛素作用的缺陷,胰岛素清除和最终β细胞分泌功能将被细胞内甘油三酯在多种组织中的积累精确地抑制,所述组织包括肝细胞和骨骼肌细胞内,如监测的非并且这提供了与胰岛素中脂质代谢异常的全身器官功能障碍的统一联系抵抗综合征 初步数据支持我们的方法的可行性以及我们的假设。 对β细胞-脂质相互作用的更好理解应该为未来预防2型糖尿病的饮食建议提供证据。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DANIEL T STEIN其他文献
DANIEL T STEIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DANIEL T STEIN', 18)}}的其他基金
A Janus Robotic Multi-Assay System for Quantitative Biomarker Research
用于定量生物标志物研究的 Janus 机器人多重测定系统
- 批准号:
7795635 - 财政年份:2010
- 资助金额:
$ 31.31万 - 项目类别:
Role of Insulin Biosynthesis in Glucose Tolerance
胰岛素生物合成在葡萄糖耐量中的作用
- 批准号:
8009165 - 财政年份:2010
- 资助金额:
$ 31.31万 - 项目类别:
Role of Insulin Biosynthesis in Glucose Tolerance
胰岛素生物合成在葡萄糖耐量中的作用
- 批准号:
8494612 - 财政年份:2002
- 资助金额:
$ 31.31万 - 项目类别:
Role of Free Fatty Acids in Human Insulin Metabolism
游离脂肪酸在人体胰岛素代谢中的作用
- 批准号:
6623515 - 财政年份:2002
- 资助金额:
$ 31.31万 - 项目类别:
Role of Free Fatty Acids on Human Insulin Metabolism
游离脂肪酸对人体胰岛素代谢的作用
- 批准号:
7565067 - 财政年份:2002
- 资助金额:
$ 31.31万 - 项目类别:
Role of Free Fatty Acids in Human Insulin Metabolism
游离脂肪酸在人体胰岛素代谢中的作用
- 批准号:
6892064 - 财政年份:2002
- 资助金额:
$ 31.31万 - 项目类别:
Role of Insulin Biosynthesis in Glucose Tolerance
胰岛素生物合成在葡萄糖耐量中的作用
- 批准号:
7842475 - 财政年份:2002
- 资助金额:
$ 31.31万 - 项目类别:
Role of Insulin Biosynthesis in Glucose Tolerance
胰岛素生物合成在葡萄糖耐量中的作用
- 批准号:
8121422 - 财政年份:2002
- 资助金额:
$ 31.31万 - 项目类别:
Role of Insulin Biosynthesis in Glucose Tolerance
胰岛素生物合成在葡萄糖耐量中的作用
- 批准号:
7668845 - 财政年份:2002
- 资助金额:
$ 31.31万 - 项目类别:
Role of Insulin Biosynthesis in Glucose Tolerance
胰岛素生物合成在葡萄糖耐量中的作用
- 批准号:
9135791 - 财政年份:2002
- 资助金额:
$ 31.31万 - 项目类别:
相似海外基金
FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
- 批准号:
EP/Y036395/1 - 财政年份:2024
- 资助金额:
$ 31.31万 - 项目类别:
Research Grant
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
- 批准号:
10764456 - 财政年份:2023
- 资助金额:
$ 31.31万 - 项目类别:
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 31.31万 - 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
- 批准号:
10743328 - 财政年份:2023
- 资助金额:
$ 31.31万 - 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
- 批准号:
10638813 - 财政年份:2023
- 资助金额:
$ 31.31万 - 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
- 批准号:
10828665 - 财政年份:2023
- 资助金额:
$ 31.31万 - 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
- 批准号:
10823828 - 财政年份:2023
- 资助金额:
$ 31.31万 - 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
- 批准号:
10721095 - 财政年份:2023
- 资助金额:
$ 31.31万 - 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
- 批准号:
10795328 - 财政年份:2023
- 资助金额:
$ 31.31万 - 项目类别:
Mentoring Scientists for Careers in HIV Translational Clinical Research
指导科学家从事艾滋病毒转化临床研究
- 批准号:
10762827 - 财政年份:2023
- 资助金额:
$ 31.31万 - 项目类别:














{{item.name}}会员




